TOXICOLOGY MECHANISMS AND METHODS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1234742, encodeId=46541234e425c, content=投稿命中率:75.0 偏重的研究方向：毒理学 经验分享：在Taylor & Francis 系统里看到7月3号显示Out of review，但登录期刊官网一直显示Awaiting reviewer assignement，请问这是还在找审稿人吗？投出去一个半月了还没消息，可以给编辑发邮件询问吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be036420611, createdName=ms1000000641456923, createdTime=Tue Jul 26 00:26:40 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065335, encodeId=eed2106533556, content=审稿速度:24.0 经验分享：请问一下大家Awaiting reviewer selection这个状态会持续多久？我等了10天了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/c21edec5d1d7490b95f6d1959a2f2878/04667cfa25134b4f959a17e3e0391ff1.png, createdBy=0c105585612, createdName=ms4000001889485463, createdTime=Sat Oct 30 19:05:02 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999449, encodeId=67c29994491c, content=想问一下，6月28日显示with editor，现在7月14日还显示with editor正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88fa5542237, createdName=ms3000001052376717, createdTime=Wed Jul 14 16:34:31 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207841, encodeId=705d120e84195, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：史上最慢杂志！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34c72166258, createdName=1204189fm27(暂无昵称), createdTime=Fri Apr 01 14:15:59 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207545, encodeId=35a4120e545e9, content=审稿速度:24.0 经验分享：只能用一个字“慢”来形容！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34c72166258, createdName=1204189fm27(暂无昵称), createdTime=Thu Mar 31 14:38:53 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553062, encodeId=2bab553062da, content=大家好，我想问一下这个杂志收不收中药提取物毒性机制研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8202215057, createdName=120e33fdm49(暂无昵称), createdTime=Tue Feb 27 16:09:00 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099021, encodeId=a9e6109902142, content=什么样的图表可以用来发文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099022, encodeId=2afa10990220f, content=一般期刊要求图表的格式是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057233, encodeId=f6c6105e233b3, content=审稿速度:24.0 | 投稿命中率:5.0 | 版面费用:1200.0 偏重的研究方向：细胞毒理 经验分享：很难投，编辑有点慢，审稿人不好找, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=390, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6132152785, createdName=叽叽叽叽呱, createdTime=Sun Oct 03 19:37:21 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066194, encodeId=bda4106619482, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：投的meta，中了，不要版面费，编辑很友好，效率很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88fa5542237, createdName=ms3000001052376717, createdTime=Tue Nov 02 12:17:38 CST 2021, time=2021-11-02, status=1, ipAttribution=)]

2022-07-26 ms1000000641456923

投稿命中率:75.0
偏重的研究方向：毒理学
经验分享：在Taylor & Francis 系统里看到7月3号显示Out of review，但登录期刊官网一直显示Awaiting reviewer assignement，请问这是还在找审稿人吗？投出去一个半月了还没消息，可以给编辑发邮件询问吗？

114 0

[GetPortalCommentsPageByObjectIdResponse(id=1234742, encodeId=46541234e425c, content=投稿命中率:75.0 偏重的研究方向：毒理学 经验分享：在Taylor & Francis 系统里看到7月3号显示Out of review，但登录期刊官网一直显示Awaiting reviewer assignement，请问这是还在找审稿人吗？投出去一个半月了还没消息，可以给编辑发邮件询问吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be036420611, createdName=ms1000000641456923, createdTime=Tue Jul 26 00:26:40 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065335, encodeId=eed2106533556, content=审稿速度:24.0 经验分享：请问一下大家Awaiting reviewer selection这个状态会持续多久？我等了10天了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/c21edec5d1d7490b95f6d1959a2f2878/04667cfa25134b4f959a17e3e0391ff1.png, createdBy=0c105585612, createdName=ms4000001889485463, createdTime=Sat Oct 30 19:05:02 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999449, encodeId=67c29994491c, content=想问一下，6月28日显示with editor，现在7月14日还显示with editor正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88fa5542237, createdName=ms3000001052376717, createdTime=Wed Jul 14 16:34:31 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207841, encodeId=705d120e84195, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：史上最慢杂志！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34c72166258, createdName=1204189fm27(暂无昵称), createdTime=Fri Apr 01 14:15:59 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207545, encodeId=35a4120e545e9, content=审稿速度:24.0 经验分享：只能用一个字“慢”来形容！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34c72166258, createdName=1204189fm27(暂无昵称), createdTime=Thu Mar 31 14:38:53 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553062, encodeId=2bab553062da, content=大家好，我想问一下这个杂志收不收中药提取物毒性机制研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8202215057, createdName=120e33fdm49(暂无昵称), createdTime=Tue Feb 27 16:09:00 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099021, encodeId=a9e6109902142, content=什么样的图表可以用来发文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099022, encodeId=2afa10990220f, content=一般期刊要求图表的格式是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057233, encodeId=f6c6105e233b3, content=审稿速度:24.0 | 投稿命中率:5.0 | 版面费用:1200.0 偏重的研究方向：细胞毒理 经验分享：很难投，编辑有点慢，审稿人不好找, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=390, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6132152785, createdName=叽叽叽叽呱, createdTime=Sun Oct 03 19:37:21 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066194, encodeId=bda4106619482, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：投的meta，中了，不要版面费，编辑很友好，效率很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88fa5542237, createdName=ms3000001052376717, createdTime=Tue Nov 02 12:17:38 CST 2021, time=2021-11-02, status=1, ipAttribution=)]

2021-10-30 ms4000001889485463

审稿速度:24.0
经验分享：请问一下大家Awaiting reviewer selection这个状态会持续多久？我等了10天了。

192 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1234742, encodeId=46541234e425c, content=投稿命中率:75.0 偏重的研究方向：毒理学 经验分享：在Taylor & Francis 系统里看到7月3号显示Out of review，但登录期刊官网一直显示Awaiting reviewer assignement，请问这是还在找审稿人吗？投出去一个半月了还没消息，可以给编辑发邮件询问吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be036420611, createdName=ms1000000641456923, createdTime=Tue Jul 26 00:26:40 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065335, encodeId=eed2106533556, content=审稿速度:24.0 经验分享：请问一下大家Awaiting reviewer selection这个状态会持续多久？我等了10天了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/c21edec5d1d7490b95f6d1959a2f2878/04667cfa25134b4f959a17e3e0391ff1.png, createdBy=0c105585612, createdName=ms4000001889485463, createdTime=Sat Oct 30 19:05:02 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999449, encodeId=67c29994491c, content=想问一下，6月28日显示with editor，现在7月14日还显示with editor正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88fa5542237, createdName=ms3000001052376717, createdTime=Wed Jul 14 16:34:31 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207841, encodeId=705d120e84195, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：史上最慢杂志！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34c72166258, createdName=1204189fm27(暂无昵称), createdTime=Fri Apr 01 14:15:59 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207545, encodeId=35a4120e545e9, content=审稿速度:24.0 经验分享：只能用一个字“慢”来形容！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34c72166258, createdName=1204189fm27(暂无昵称), createdTime=Thu Mar 31 14:38:53 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553062, encodeId=2bab553062da, content=大家好，我想问一下这个杂志收不收中药提取物毒性机制研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8202215057, createdName=120e33fdm49(暂无昵称), createdTime=Tue Feb 27 16:09:00 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099021, encodeId=a9e6109902142, content=什么样的图表可以用来发文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099022, encodeId=2afa10990220f, content=一般期刊要求图表的格式是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057233, encodeId=f6c6105e233b3, content=审稿速度:24.0 | 投稿命中率:5.0 | 版面费用:1200.0 偏重的研究方向：细胞毒理 经验分享：很难投，编辑有点慢，审稿人不好找, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=390, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6132152785, createdName=叽叽叽叽呱, createdTime=Sun Oct 03 19:37:21 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066194, encodeId=bda4106619482, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：投的meta，中了，不要版面费，编辑很友好，效率很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88fa5542237, createdName=ms3000001052376717, createdTime=Tue Nov 02 12:17:38 CST 2021, time=2021-11-02, status=1, ipAttribution=)]

2021-07-14 ms3000001052376717

想问一下，6月28日显示with editor，现在7月14日还显示with editor正常吗？

279 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1234742, encodeId=46541234e425c, content=投稿命中率:75.0 偏重的研究方向：毒理学 经验分享：在Taylor & Francis 系统里看到7月3号显示Out of review，但登录期刊官网一直显示Awaiting reviewer assignement，请问这是还在找审稿人吗？投出去一个半月了还没消息，可以给编辑发邮件询问吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be036420611, createdName=ms1000000641456923, createdTime=Tue Jul 26 00:26:40 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065335, encodeId=eed2106533556, content=审稿速度:24.0 经验分享：请问一下大家Awaiting reviewer selection这个状态会持续多久？我等了10天了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/c21edec5d1d7490b95f6d1959a2f2878/04667cfa25134b4f959a17e3e0391ff1.png, createdBy=0c105585612, createdName=ms4000001889485463, createdTime=Sat Oct 30 19:05:02 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999449, encodeId=67c29994491c, content=想问一下，6月28日显示with editor，现在7月14日还显示with editor正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88fa5542237, createdName=ms3000001052376717, createdTime=Wed Jul 14 16:34:31 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207841, encodeId=705d120e84195, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：史上最慢杂志！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34c72166258, createdName=1204189fm27(暂无昵称), createdTime=Fri Apr 01 14:15:59 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207545, encodeId=35a4120e545e9, content=审稿速度:24.0 经验分享：只能用一个字“慢”来形容！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34c72166258, createdName=1204189fm27(暂无昵称), createdTime=Thu Mar 31 14:38:53 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553062, encodeId=2bab553062da, content=大家好，我想问一下这个杂志收不收中药提取物毒性机制研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8202215057, createdName=120e33fdm49(暂无昵称), createdTime=Tue Feb 27 16:09:00 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099021, encodeId=a9e6109902142, content=什么样的图表可以用来发文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099022, encodeId=2afa10990220f, content=一般期刊要求图表的格式是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057233, encodeId=f6c6105e233b3, content=审稿速度:24.0 | 投稿命中率:5.0 | 版面费用:1200.0 偏重的研究方向：细胞毒理 经验分享：很难投，编辑有点慢，审稿人不好找, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=390, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6132152785, createdName=叽叽叽叽呱, createdTime=Sun Oct 03 19:37:21 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066194, encodeId=bda4106619482, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：投的meta，中了，不要版面费，编辑很友好，效率很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88fa5542237, createdName=ms3000001052376717, createdTime=Tue Nov 02 12:17:38 CST 2021, time=2021-11-02, status=1, ipAttribution=)]

2022-04-01 1204189fm27(暂无昵称)

审稿速度:24.0 | 投稿命中率:5.0
经验分享：史上最慢杂志！

108 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1234742, encodeId=46541234e425c, content=投稿命中率:75.0 偏重的研究方向：毒理学 经验分享：在Taylor & Francis 系统里看到7月3号显示Out of review，但登录期刊官网一直显示Awaiting reviewer assignement，请问这是还在找审稿人吗？投出去一个半月了还没消息，可以给编辑发邮件询问吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be036420611, createdName=ms1000000641456923, createdTime=Tue Jul 26 00:26:40 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065335, encodeId=eed2106533556, content=审稿速度:24.0 经验分享：请问一下大家Awaiting reviewer selection这个状态会持续多久？我等了10天了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/c21edec5d1d7490b95f6d1959a2f2878/04667cfa25134b4f959a17e3e0391ff1.png, createdBy=0c105585612, createdName=ms4000001889485463, createdTime=Sat Oct 30 19:05:02 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999449, encodeId=67c29994491c, content=想问一下，6月28日显示with editor，现在7月14日还显示with editor正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88fa5542237, createdName=ms3000001052376717, createdTime=Wed Jul 14 16:34:31 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207841, encodeId=705d120e84195, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：史上最慢杂志！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34c72166258, createdName=1204189fm27(暂无昵称), createdTime=Fri Apr 01 14:15:59 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207545, encodeId=35a4120e545e9, content=审稿速度:24.0 经验分享：只能用一个字“慢”来形容！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34c72166258, createdName=1204189fm27(暂无昵称), createdTime=Thu Mar 31 14:38:53 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553062, encodeId=2bab553062da, content=大家好，我想问一下这个杂志收不收中药提取物毒性机制研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8202215057, createdName=120e33fdm49(暂无昵称), createdTime=Tue Feb 27 16:09:00 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099021, encodeId=a9e6109902142, content=什么样的图表可以用来发文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099022, encodeId=2afa10990220f, content=一般期刊要求图表的格式是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057233, encodeId=f6c6105e233b3, content=审稿速度:24.0 | 投稿命中率:5.0 | 版面费用:1200.0 偏重的研究方向：细胞毒理 经验分享：很难投，编辑有点慢，审稿人不好找, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=390, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6132152785, createdName=叽叽叽叽呱, createdTime=Sun Oct 03 19:37:21 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066194, encodeId=bda4106619482, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：投的meta，中了，不要版面费，编辑很友好，效率很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88fa5542237, createdName=ms3000001052376717, createdTime=Tue Nov 02 12:17:38 CST 2021, time=2021-11-02, status=1, ipAttribution=)]

2022-03-31 1204189fm27(暂无昵称)

审稿速度:24.0
经验分享：只能用一个字“慢”来形容！

107 0

[GetPortalCommentsPageByObjectIdResponse(id=1234742, encodeId=46541234e425c, content=投稿命中率:75.0 偏重的研究方向：毒理学 经验分享：在Taylor & Francis 系统里看到7月3号显示Out of review，但登录期刊官网一直显示Awaiting reviewer assignement，请问这是还在找审稿人吗？投出去一个半月了还没消息，可以给编辑发邮件询问吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be036420611, createdName=ms1000000641456923, createdTime=Tue Jul 26 00:26:40 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065335, encodeId=eed2106533556, content=审稿速度:24.0 经验分享：请问一下大家Awaiting reviewer selection这个状态会持续多久？我等了10天了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/c21edec5d1d7490b95f6d1959a2f2878/04667cfa25134b4f959a17e3e0391ff1.png, createdBy=0c105585612, createdName=ms4000001889485463, createdTime=Sat Oct 30 19:05:02 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999449, encodeId=67c29994491c, content=想问一下，6月28日显示with editor，现在7月14日还显示with editor正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88fa5542237, createdName=ms3000001052376717, createdTime=Wed Jul 14 16:34:31 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207841, encodeId=705d120e84195, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：史上最慢杂志！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34c72166258, createdName=1204189fm27(暂无昵称), createdTime=Fri Apr 01 14:15:59 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207545, encodeId=35a4120e545e9, content=审稿速度:24.0 经验分享：只能用一个字“慢”来形容！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34c72166258, createdName=1204189fm27(暂无昵称), createdTime=Thu Mar 31 14:38:53 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553062, encodeId=2bab553062da, content=大家好，我想问一下这个杂志收不收中药提取物毒性机制研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8202215057, createdName=120e33fdm49(暂无昵称), createdTime=Tue Feb 27 16:09:00 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099021, encodeId=a9e6109902142, content=什么样的图表可以用来发文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099022, encodeId=2afa10990220f, content=一般期刊要求图表的格式是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057233, encodeId=f6c6105e233b3, content=审稿速度:24.0 | 投稿命中率:5.0 | 版面费用:1200.0 偏重的研究方向：细胞毒理 经验分享：很难投，编辑有点慢，审稿人不好找, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=390, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6132152785, createdName=叽叽叽叽呱, createdTime=Sun Oct 03 19:37:21 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066194, encodeId=bda4106619482, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：投的meta，中了，不要版面费，编辑很友好，效率很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88fa5542237, createdName=ms3000001052376717, createdTime=Tue Nov 02 12:17:38 CST 2021, time=2021-11-02, status=1, ipAttribution=)]

2018-02-27 120e33fdm49(暂无昵称)

大家好，我想问一下这个杂志收不收中药提取物毒性机制研究

338 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1234742, encodeId=46541234e425c, content=投稿命中率:75.0 偏重的研究方向：毒理学 经验分享：在Taylor & Francis 系统里看到7月3号显示Out of review，但登录期刊官网一直显示Awaiting reviewer assignement，请问这是还在找审稿人吗？投出去一个半月了还没消息，可以给编辑发邮件询问吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be036420611, createdName=ms1000000641456923, createdTime=Tue Jul 26 00:26:40 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065335, encodeId=eed2106533556, content=审稿速度:24.0 经验分享：请问一下大家Awaiting reviewer selection这个状态会持续多久？我等了10天了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/c21edec5d1d7490b95f6d1959a2f2878/04667cfa25134b4f959a17e3e0391ff1.png, createdBy=0c105585612, createdName=ms4000001889485463, createdTime=Sat Oct 30 19:05:02 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999449, encodeId=67c29994491c, content=想问一下，6月28日显示with editor，现在7月14日还显示with editor正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88fa5542237, createdName=ms3000001052376717, createdTime=Wed Jul 14 16:34:31 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207841, encodeId=705d120e84195, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：史上最慢杂志！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34c72166258, createdName=1204189fm27(暂无昵称), createdTime=Fri Apr 01 14:15:59 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207545, encodeId=35a4120e545e9, content=审稿速度:24.0 经验分享：只能用一个字“慢”来形容！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34c72166258, createdName=1204189fm27(暂无昵称), createdTime=Thu Mar 31 14:38:53 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553062, encodeId=2bab553062da, content=大家好，我想问一下这个杂志收不收中药提取物毒性机制研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8202215057, createdName=120e33fdm49(暂无昵称), createdTime=Tue Feb 27 16:09:00 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099021, encodeId=a9e6109902142, content=什么样的图表可以用来发文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099022, encodeId=2afa10990220f, content=一般期刊要求图表的格式是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057233, encodeId=f6c6105e233b3, content=审稿速度:24.0 | 投稿命中率:5.0 | 版面费用:1200.0 偏重的研究方向：细胞毒理 经验分享：很难投，编辑有点慢，审稿人不好找, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=390, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6132152785, createdName=叽叽叽叽呱, createdTime=Sun Oct 03 19:37:21 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066194, encodeId=bda4106619482, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：投的meta，中了，不要版面费，编辑很友好，效率很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88fa5542237, createdName=ms3000001052376717, createdTime=Tue Nov 02 12:17:38 CST 2021, time=2021-11-02, status=1, ipAttribution=)]

2021-12-28 rayms

什么样的图表可以用来发文章？

114 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1234742, encodeId=46541234e425c, content=投稿命中率:75.0 偏重的研究方向：毒理学 经验分享：在Taylor & Francis 系统里看到7月3号显示Out of review，但登录期刊官网一直显示Awaiting reviewer assignement，请问这是还在找审稿人吗？投出去一个半月了还没消息，可以给编辑发邮件询问吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be036420611, createdName=ms1000000641456923, createdTime=Tue Jul 26 00:26:40 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065335, encodeId=eed2106533556, content=审稿速度:24.0 经验分享：请问一下大家Awaiting reviewer selection这个状态会持续多久？我等了10天了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/c21edec5d1d7490b95f6d1959a2f2878/04667cfa25134b4f959a17e3e0391ff1.png, createdBy=0c105585612, createdName=ms4000001889485463, createdTime=Sat Oct 30 19:05:02 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999449, encodeId=67c29994491c, content=想问一下，6月28日显示with editor，现在7月14日还显示with editor正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88fa5542237, createdName=ms3000001052376717, createdTime=Wed Jul 14 16:34:31 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207841, encodeId=705d120e84195, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：史上最慢杂志！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34c72166258, createdName=1204189fm27(暂无昵称), createdTime=Fri Apr 01 14:15:59 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207545, encodeId=35a4120e545e9, content=审稿速度:24.0 经验分享：只能用一个字“慢”来形容！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34c72166258, createdName=1204189fm27(暂无昵称), createdTime=Thu Mar 31 14:38:53 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553062, encodeId=2bab553062da, content=大家好，我想问一下这个杂志收不收中药提取物毒性机制研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8202215057, createdName=120e33fdm49(暂无昵称), createdTime=Tue Feb 27 16:09:00 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099021, encodeId=a9e6109902142, content=什么样的图表可以用来发文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099022, encodeId=2afa10990220f, content=一般期刊要求图表的格式是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057233, encodeId=f6c6105e233b3, content=审稿速度:24.0 | 投稿命中率:5.0 | 版面费用:1200.0 偏重的研究方向：细胞毒理 经验分享：很难投，编辑有点慢，审稿人不好找, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=390, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6132152785, createdName=叽叽叽叽呱, createdTime=Sun Oct 03 19:37:21 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066194, encodeId=bda4106619482, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：投的meta，中了，不要版面费，编辑很友好，效率很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88fa5542237, createdName=ms3000001052376717, createdTime=Tue Nov 02 12:17:38 CST 2021, time=2021-11-02, status=1, ipAttribution=)]

2021-12-27 msSSSSSD

一般期刊要求图表的格式是什么？

119 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1234742, encodeId=46541234e425c, content=投稿命中率:75.0 偏重的研究方向：毒理学 经验分享：在Taylor & Francis 系统里看到7月3号显示Out of review，但登录期刊官网一直显示Awaiting reviewer assignement，请问这是还在找审稿人吗？投出去一个半月了还没消息，可以给编辑发邮件询问吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be036420611, createdName=ms1000000641456923, createdTime=Tue Jul 26 00:26:40 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065335, encodeId=eed2106533556, content=审稿速度:24.0 经验分享：请问一下大家Awaiting reviewer selection这个状态会持续多久？我等了10天了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/c21edec5d1d7490b95f6d1959a2f2878/04667cfa25134b4f959a17e3e0391ff1.png, createdBy=0c105585612, createdName=ms4000001889485463, createdTime=Sat Oct 30 19:05:02 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999449, encodeId=67c29994491c, content=想问一下，6月28日显示with editor，现在7月14日还显示with editor正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88fa5542237, createdName=ms3000001052376717, createdTime=Wed Jul 14 16:34:31 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207841, encodeId=705d120e84195, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：史上最慢杂志！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34c72166258, createdName=1204189fm27(暂无昵称), createdTime=Fri Apr 01 14:15:59 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207545, encodeId=35a4120e545e9, content=审稿速度:24.0 经验分享：只能用一个字“慢”来形容！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34c72166258, createdName=1204189fm27(暂无昵称), createdTime=Thu Mar 31 14:38:53 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553062, encodeId=2bab553062da, content=大家好，我想问一下这个杂志收不收中药提取物毒性机制研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8202215057, createdName=120e33fdm49(暂无昵称), createdTime=Tue Feb 27 16:09:00 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099021, encodeId=a9e6109902142, content=什么样的图表可以用来发文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099022, encodeId=2afa10990220f, content=一般期刊要求图表的格式是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057233, encodeId=f6c6105e233b3, content=审稿速度:24.0 | 投稿命中率:5.0 | 版面费用:1200.0 偏重的研究方向：细胞毒理 经验分享：很难投，编辑有点慢，审稿人不好找, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=390, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6132152785, createdName=叽叽叽叽呱, createdTime=Sun Oct 03 19:37:21 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066194, encodeId=bda4106619482, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：投的meta，中了，不要版面费，编辑很友好，效率很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88fa5542237, createdName=ms3000001052376717, createdTime=Tue Nov 02 12:17:38 CST 2021, time=2021-11-02, status=1, ipAttribution=)]

2021-10-03 叽叽叽叽呱

审稿速度:24.0 | 投稿命中率:5.0 | 版面费用:1200.0
偏重的研究方向：细胞毒理
经验分享：很难投，编辑有点慢，审稿人不好找

390 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1234742, encodeId=46541234e425c, content=投稿命中率:75.0 偏重的研究方向：毒理学 经验分享：在Taylor & Francis 系统里看到7月3号显示Out of review，但登录期刊官网一直显示Awaiting reviewer assignement，请问这是还在找审稿人吗？投出去一个半月了还没消息，可以给编辑发邮件询问吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be036420611, createdName=ms1000000641456923, createdTime=Tue Jul 26 00:26:40 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065335, encodeId=eed2106533556, content=审稿速度:24.0 经验分享：请问一下大家Awaiting reviewer selection这个状态会持续多久？我等了10天了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/c21edec5d1d7490b95f6d1959a2f2878/04667cfa25134b4f959a17e3e0391ff1.png, createdBy=0c105585612, createdName=ms4000001889485463, createdTime=Sat Oct 30 19:05:02 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999449, encodeId=67c29994491c, content=想问一下，6月28日显示with editor，现在7月14日还显示with editor正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88fa5542237, createdName=ms3000001052376717, createdTime=Wed Jul 14 16:34:31 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207841, encodeId=705d120e84195, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：史上最慢杂志！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34c72166258, createdName=1204189fm27(暂无昵称), createdTime=Fri Apr 01 14:15:59 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207545, encodeId=35a4120e545e9, content=审稿速度:24.0 经验分享：只能用一个字“慢”来形容！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34c72166258, createdName=1204189fm27(暂无昵称), createdTime=Thu Mar 31 14:38:53 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553062, encodeId=2bab553062da, content=大家好，我想问一下这个杂志收不收中药提取物毒性机制研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8202215057, createdName=120e33fdm49(暂无昵称), createdTime=Tue Feb 27 16:09:00 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099021, encodeId=a9e6109902142, content=什么样的图表可以用来发文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099022, encodeId=2afa10990220f, content=一般期刊要求图表的格式是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057233, encodeId=f6c6105e233b3, content=审稿速度:24.0 | 投稿命中率:5.0 | 版面费用:1200.0 偏重的研究方向：细胞毒理 经验分享：很难投，编辑有点慢，审稿人不好找, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=390, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6132152785, createdName=叽叽叽叽呱, createdTime=Sun Oct 03 19:37:21 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066194, encodeId=bda4106619482, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：投的meta，中了，不要版面费，编辑很友好，效率很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88fa5542237, createdName=ms3000001052376717, createdTime=Tue Nov 02 12:17:38 CST 2021, time=2021-11-02, status=1, ipAttribution=)]

2021-11-02 ms3000001052376717

审稿速度:2.0 | 投稿命中率:95.0
经验分享：投的meta，中了，不要版面费，编辑很友好，效率很快

125 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务